QBFM
LFCR icon

QS Batterymarch Financial Management’s Lifecore Biomedical LFCR Stock Holding History

QS Batterymarch Financial Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-34,672
Closed -$434K – 921
2014
Q2 		$434K Sell
34,672
-70,040
-67% -$824K 0.01% 599
2014
Q1 		$1.17M Sell
104,712
-86,308
-45% -$947K 0.02% 627
2013
Q4 		$2.32M Sell
191,020
-31,370
-14% -$375K 0.05% 457
2013
Q3 		$2.71M Sell
222,390
-9,750
-4% -$136K 0.06% 430
2013
Q2 		$3.07M Buy
+232,140
New +$3.21M 0.06% 442

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

QS Batterymarch Financial Management's LFCR Position: Q3 2014 in Review

QS Batterymarch Financial Management sold out of Lifecore Biomedical (LFCR) in Q3 2014, closing a stake of 34,672 shares — an estimated $434K sold.

QS Batterymarch Financial Management first reported a position in LFCR in Q2 2013 and held it in 5 quarters. The position peaked at $3.07M in Q2 2013. 107 funds tracked by Wall St. Rank hold LFCR as of Q3 2014.

  • QS Batterymarch Financial Management reported no remaining Lifecore Biomedical position as of Q3 2014 after selling out during the quarter.
  • QS Batterymarch Financial Management sold 34,672 Lifecore Biomedical shares in Q3 2014, an estimated $434K.
  • QS Batterymarch Financial Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 5 quarters.
  • QS Batterymarch Financial Management's Lifecore Biomedical position peaked at $3.07M in Q2 2013.
  • 107 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.